Shares of Std Life Aberdeen (OTCMKTS:SLFPF) have received a consensus rating of “Buy” from the six research firms that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company.
Several equities research analysts have recently commented on the stock. Barclays PLC raised shares of Std Life Aberdeen from an “underweight” rating to an “overweight” rating in a research report on Tuesday, August 15th. BNP Paribas raised shares of Std Life Aberdeen from a “neutral” rating to an “outperform” rating in a research report on Thursday, August 3rd.
ILLEGAL ACTIVITY WARNING: This report was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.dispatchtribunal.com/2017/11/12/std-life-aberdeen-slfpf-receives-average-rating-of-buy-from-brokerages.html.
Shares of Std Life Aberdeen (OTCMKTS SLFPF) opened at $5.40 on Friday. Std Life Aberdeen has a 12-month low of $4.27 and a 12-month high of $5.89.
About Std Life Aberdeen
Receive News & Ratings for Std Life Aberdeen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Std Life Aberdeen and related companies with MarketBeat.com's FREE daily email newsletter.